Literature DB >> 12831419

Helium-oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation.

Shamel A Abd-Allah1, Mark S Rogers, Michael Terry, Matthew Gross, Ronald M Perkin.   

Abstract

OBJECTIVE: To illustrate the use of helium-oxygen gas mixtures as therapy for pediatric patients with acute severe asthma requiring conventional mechanical ventilation.
DESIGN: Retrospective review.
SETTING: Tertiary care children's teaching hospital. PATIENTS: All mechanically ventilated patients with severe asthma admitted to the pediatric intensive care unit from August 1994 to October 2000.
INTERVENTIONS: Within 24 hrs of intubation or admission, patients were stabilized on volume ventilation, bronchodilator therapy, corticosteroids, and antibiotics when indicated. Hypercapnia was permitted while maintaining arterial blood gas pH > or =7.25. A helium-oxygen gas mixture then was begun with helium flow set at 5-7 L/min, and oxygen flow was titrated to maintain desired oxygen saturation. Only sedated, chemically paralyzed patients with adequate pre-helium-oxygen and post-helium-oxygen measurements were statistically analyzed.
MEASUREMENTS AND MAIN RESULTS: Twenty-eight mechanically ventilated patients with severe asthma placed on helium-oxygen gas mixtures were identified who met study entry criteria. Mean patient age was 8.8 yrs (range, 1.1-14.6). Before helium-oxygen therapy began, mean peak inspiratory pressure was 40.5 +/- 4.2 cm H(2)O, mean arterial blood gas pH was 7.26 +/- 0.05, and mean CO(2) partial pressure was 58.2 +/- 8.5 torr. After patients were placed on helium-oxygen therapy, there was a significant decrease in mean peak inspiratory pressure to 35.3 +/- 3.0 cm H(2)O. Mean pH increased significantly to 7.32 +/- 0.06, and mean partial pressure CO(2) decreased significantly to 50.5 +/- 7.4 torr. Initial mean inspired helium was 57 +/- 4% (range, 32-74). Mechanical ventilation days ranged from 1 to 23 days (mean, 5.0). Hospital stay ranged from 4 to 29 days (mean, 10.1), with an average pediatric intensive care unit stay of 6.9 days (range, 2-24). There were two incidences of pneumothorax.
CONCLUSIONS: In the pediatric patient with severe asthma requiring conventional mechanical ventilation, helium-oxygen administration appears to be a safe therapy and may assist in lowering peak inspiratory pressure and improving blood gas pH and partial pressure CO(2).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12831419     DOI: 10.1097/01.PCC.0000074267.11280.78

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  7 in total

1.  Mechanical ventilation with heliox decreases respiratory system resistance and facilitates CO2 removal in obstructive airway disease.

Authors:  Martin C J Kneyber; Marc van Heerde; Dick G Markhorst; Frans B Plötz
Journal:  Intensive Care Med       Date:  2006-08-23       Impact factor: 17.440

2.  Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit.

Authors:  I Federico Fernandez Nievas; Kanwaljeet J S Anand
Journal:  J Pediatr Pharmacol Ther       Date:  2013-04

Review 3.  Clinical review: use of helium-oxygen in critically ill patients.

Authors:  Marc Gainnier; Jean-Marie Forel
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

4.  Heliox allows for lower minute volume ventilation in an animal model of ventilator-induced lung injury.

Authors:  Charlotte J Beurskens; Hamid Aslami; Friso M de Beer; Margreeth B Vroom; Benedikt Preckel; Janneke Horn; Nicole P Juffermans
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

5.  Heliox Improves Carbon Dioxide Removal during Lung Protective Mechanical Ventilation.

Authors:  Charlotte J Beurskens; Daniel Brevoord; Wim K Lagrand; Walter M van den Bergh; Margreeth B Vroom; Benedikt Preckel; Janneke Horn; Nicole P Juffermans
Journal:  Crit Care Res Pract       Date:  2014-12-07

6.  Mechanical ventilation with heliox in an animal model of acute respiratory distress syndrome.

Authors:  Charlotte J Beurskens; Hamid Aslami; Friso M de Beer; Joris Jth Roelofs; Margreeth B Vroom; Nicole P Juffermans
Journal:  Intensive Care Med Exp       Date:  2014-02-06

7.  A randomized trial of the effects of the noble gases helium and argon on neuroprotection in a rodent cardiac arrest model.

Authors:  Patrick Zuercher; Dirk Springe; Denis Grandgirard; Stephen L Leib; Marius Grossholz; Stephan Jakob; Jukka Takala; Matthias Haenggi
Journal:  BMC Neurol       Date:  2016-04-04       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.